China Central Economic Work Conference: A Key Indicator for Future Market Trends
Tonight, Chinese concepts soared! The nasdaq Golden Dragon index surged by 10%, while fangdd network doubled directly.
Some analysis indicates that the Political Bureau meeting first mentioned stabilizing the stock and real estate markets, and the US stock market quickly rallied on china assets. The 3x Long FTSE china etf surged over 26%, the 2x Long china internet plus-related stocks rose over 22%, the 2x Long FTSE china 50 ETF increased over 17%, and the 2x Long 300etf gained nearly 15%.
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011
Express News | Beyondspring Presents Updated Efficacy Results From a Phase 2 Iit Study of Triple IO Combo of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic Nsclc After Progressing on Prior Immune Checkpoint Inhibitors at the 39TH SITC Annual Meeting
BeyondSpring Presents Updated Efficacy Results From a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual Meeting
Express News | U.S.-Listed Shares of Chinese Firms Drop Premarket on Worries Over Growing U.S.-China Trade Tensions Under Trump Presidency
Goldman Sachs Raises China Economic Growth Forecasts
China's Stocks Lose Steam as Enthusiasm for Major Stimulus Wanes. What's Next?
Today's Pre-Market Movers and Top Ratings | LI, BABA, NKE and More
Express News | Hedge Funds Are Pouring Into ETFs Focusing on Chinese Equities With $2.4 Billion Inflows
12 Health Care Stocks Moving In Tuesday's Intraday Session
Express News | U.S.-Listed Chinese Stocks Surge in Overnight Trading Following Politburo's Commitment to Fiscal Support
US Listed-Chinese Stocks Surge Tuesday on Policy Boost, Who Is Leading the Way
Express News | U.S.-Listed Shares of Chinese Firms Jump Premarket After China Announces Stimulus Measures
BeyondSpring Plinabulin, Merck Keytruda Combo Shows Promise in NSCLC
BeyondSpring Presents Final Data Analysis of DUBLIN-3 Phase 3 Study in 2L/3L EGFR Wild-type NSCLC at ESMO Congress 2024
BeyondSpring Presents Efficacy/Safety Results From a Phase 2 Study of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progressing on First-Line Immune Checkpoint Inhibitors at ESMO Congress 2024
BeyondSpring Presents Final Phase 3 Results For Plinabulin In 2L/3L NSCLC At ISLAC 2024, With Concurrent Publication In The Lancet Respiratory Medicine
Express News | Beyondspring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During Esmo Congress 2024 Showcasing Its Lead Anti-Cancer Asset, Plinabulin
Is BeyondSpring (NASDAQ:BYSI) In A Good Position To Invest In Growth?